COFFEE HOLDING CO INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that COFFEE HOLDING CO INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Oct 31, 2021 | $63.92M | Mar 17, 2023 |
| FY2021 | Oct 31, 2020 | $66.03M | Mar 17, 2023 |
| FY2018 | Oct 31, 2018 | $90.66M | Jan 29, 2019 |
| FY2018 | Oct 31, 2017 | $77.13M | Jan 29, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $96.28M | Jan 28, 2026 |
| FY2025 | Oct 31, 2024 | $78.56M | Jan 28, 2026 |
| FY2024 | Oct 31, 2023 | $68.17M | Jan 31, 2025 |
| FY2023 | Oct 31, 2022 | $65.71M | Feb 9, 2024 |
| FY2022 | Oct 31, 2021 | $63.92M | Mar 29, 2023 |
| FY2021 | Oct 31, 2020 | $66.03M | Mar 17, 2023 |
| FY2020 | Oct 31, 2019 | $76.61M | Mar 17, 2023 |
| FY2019 | Oct 31, 2018 | $90.66M | Jan 29, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $15.41M | Jan 28, 2026 |
| FY2025 | Oct 31, 2024 | $16.04M | Jan 28, 2026 |
| FY2024 | Oct 31, 2023 | $10.96M | Jan 31, 2025 |
| FY2023 | Oct 31, 2022 | $11.01M | Feb 9, 2024 |
| FY2022 | Oct 31, 2021 | $16.02M | Mar 29, 2023 |
| FY2021 | Oct 31, 2020 | $13.08M | Mar 17, 2023 |
| FY2020 | Oct 31, 2019 | $15.76M | Mar 17, 2023 |
| FY2019 | Oct 31, 2018 | $15.61M | Jan 29, 2020 |
| FY2018 | Oct 31, 2017 | $12.15M | Jan 29, 2019 |
| FY2017 | Oct 31, 2016 | $11.88M | Jan 29, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $1.40M | Jan 28, 2026 |
| FY2025 | Oct 31, 2024 | $2.22M | Jan 28, 2026 |
| FY2024 | Oct 31, 2023 | ($835.6K) | Jan 31, 2025 |
| FY2023 | Oct 31, 2022 | ($3.74M) | Feb 9, 2024 |
| FY2022 | Oct 31, 2021 | $1.26M | Mar 29, 2023 |
| FY2021 | Oct 31, 2020 | ($94.3K) | Mar 17, 2023 |
| FY2020 | Oct 31, 2019 | ($94.6K) | Mar 17, 2023 |
| FY2019 | Oct 31, 2018 | $1.06M | Jan 29, 2020 |
| FY2018 | Oct 31, 2017 | $467.3K | Jan 29, 2019 |
| FY2017 | Oct 31, 2016 | $2.21M | Jan 29, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $2.15M | Jan 28, 2026 |
| FY2025 | Oct 31, 2024 | $2.96M | Jan 28, 2026 |
| FY2024 | Oct 31, 2023 | ($1.33M) | Jan 31, 2025 |
| FY2023 | Oct 31, 2022 | ($5.34M) | Feb 9, 2024 |
| FY2022 | Oct 31, 2021 | $1.45M | Mar 29, 2023 |
| FY2021 | Oct 31, 2020 | ($825.3K) | Mar 17, 2023 |
| FY2020 | Oct 31, 2019 | $540.5K | Mar 17, 2023 |
| FY2019 | Oct 31, 2018 | $2.40M | Jan 29, 2020 |
| FY2018 | Oct 31, 2017 | $1.22M | Jan 29, 2019 |
| FY2017 | Oct 31, 2016 | $3.86M | Jan 29, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $12.42M | Jan 28, 2026 |
| FY2025 | Oct 31, 2024 | $12.46M | Jan 28, 2026 |
| FY2024 | Oct 31, 2023 | $11.68M | Jan 31, 2025 |
| FY2023 | Oct 31, 2022 | $12.99M | Feb 9, 2024 |
| FY2022 | Oct 31, 2021 | $12.88M | Mar 29, 2023 |
| FY2021 | Oct 31, 2020 | $13.22M | Mar 17, 2023 |
| FY2020 | Oct 31, 2019 | $14.50M | Mar 17, 2023 |
| FY2019 | Oct 31, 2018 | $12.53M | Jan 29, 2020 |
| FY2018 | Oct 31, 2017 | $10.23M | Jan 29, 2019 |
| FY2017 | Oct 31, 2016 | $7.36M | Jan 29, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | ($5.02M) | Jan 28, 2026 |
| FY2025 | Oct 31, 2024 | $5.43M | Jan 28, 2026 |
| FY2024 | Oct 31, 2023 | $652.1K | Jan 31, 2025 |
| FY2023 | Oct 31, 2022 | ($5.44M) | Feb 9, 2024 |
| FY2022 | Oct 31, 2021 | $4.71M | Mar 29, 2023 |
| FY2021 | Oct 31, 2020 | $4.39M | Mar 17, 2023 |
| FY2020 | Oct 31, 2019 | ($2.15M) | Mar 17, 2023 |
| FY2019 | Oct 31, 2018 | $8.69M | Jan 29, 2020 |
| FY2018 | Oct 31, 2017 | $1.48M | Jan 29, 2019 |
| FY2017 | Oct 31, 2016 | $1.61M | Jan 29, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $191.6K | Jan 28, 2026 |
| FY2025 | Oct 31, 2024 | $306.9K | Jan 28, 2026 |
| FY2024 | Oct 31, 2023 | $857.8K | Jan 31, 2025 |
| FY2023 | Oct 31, 2022 | $1.06M | Feb 9, 2024 |
| FY2022 | Oct 31, 2021 | $1.50M | Mar 29, 2023 |
| FY2021 | Oct 31, 2020 | $435.9K | Mar 17, 2023 |
| FY2020 | Oct 31, 2019 | $743.4K | Mar 17, 2023 |
| FY2019 | Oct 31, 2018 | $383.5K | Jan 29, 2020 |
| FY2018 | Oct 31, 2017 | $679.9K | Jan 29, 2019 |
| FY2017 | Oct 31, 2016 | $963.4K | Jan 29, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $42.05M | Jan 28, 2026 |
| FY2025 | Oct 31, 2024 | $34.01M | Jan 28, 2026 |
| FY2024 | Oct 31, 2023 | $42.19M | Jan 31, 2025 |
| FY2023 | Oct 31, 2022 | $42.69M | Feb 9, 2024 |
| FY2022 | Oct 31, 2021 | $43.31M | Mar 29, 2023 |
| FY2021 | Oct 31, 2020 | $38.36M | Mar 17, 2023 |
| FY2020 | Oct 31, 2019 | $39.69M | Mar 17, 2023 |
| FY2019 | Oct 31, 2018 | $38.83M | Jan 29, 2020 |
| FY2018 | Oct 31, 2017 | $40.00M | Jan 29, 2019 |
| FY2017 | Oct 31, 2016 | $37.02M | Jan 29, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $14.47M | Jan 28, 2026 |
| FY2025 | Oct 31, 2024 | $7.83M | Jan 28, 2026 |
| FY2024 | Oct 31, 2023 | $18.48M | Jan 31, 2025 |
| FY2023 | Oct 31, 2022 | $18.14M | Feb 9, 2024 |
| FY2022 | Oct 31, 2021 | $13.94M | Mar 29, 2023 |
| FY2021 | Oct 31, 2020 | $10.61M | Mar 17, 2023 |
| FY2020 | Oct 31, 2019 | $12.96M | Mar 17, 2023 |
| FY2019 | Oct 31, 2018 | $12.84M | Jan 29, 2020 |
| FY2018 | Oct 31, 2017 | $14.41M | Jan 29, 2019 |
| FY2017 | Oct 31, 2016 | $11.91M | Jan 29, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Oct 31, 2024 | $26.18M | Jan 31, 2025 |
| FY2024 | Oct 31, 2023 | $23.96M | Jan 31, 2025 |
| FY2023 | Oct 31, 2022 | $24.80M | Feb 9, 2024 |
| FY2022 | Oct 31, 2021 | $28.53M | Mar 29, 2023 |
| FY2021 | Oct 31, 2020 | $26.52M | Mar 17, 2023 |
| FY2020 | Oct 31, 2019 | $25.26M | Mar 17, 2023 |
| FY2019 | Oct 31, 2018 | $24.88M | Jan 29, 2020 |
| FY2018 | Oct 31, 2017 | $24.95M | Jan 29, 2019 |
| FY2017 | Oct 31, 2016 | $24.54M | Jan 29, 2018 |
| FY2016 | Oct 31, 2015 | $24.08M | Jan 27, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Oct 31, 2021 | $2.49M | Mar 29, 2023 |
| FY2021 | Oct 31, 2020 | $2.49M | Mar 17, 2023 |
| FY2020 | Oct 31, 2019 | $2.49M | Mar 17, 2023 |
| FY2019 | Oct 31, 2018 | $2.49M | Jan 29, 2020 |
| FY2018 | Oct 31, 2017 | $1.79M | Jan 29, 2019 |
| FY2017 | Oct 31, 2016 | $1.02M | Jan 29, 2018 |
| FY2016 | Oct 31, 2015 | $440.0K | Jan 27, 2017 |
| FY2015 | Oct 31, 2014 | $440.0K | Jan 26, 2016 |
| FY2014 | Oct 31, 2013 | $440.0K | Jan 23, 2015 |
| FY2013 | Oct 31, 2012 | $440.0K | Jan 24, 2014 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $13.11M | Jan 28, 2026 |
| FY2025 | Oct 31, 2024 | $11.71M | Jan 28, 2026 |
| FY2024 | Oct 31, 2023 | $9.49M | Jan 31, 2025 |
| FY2023 | Oct 31, 2022 | $10.33M | Feb 9, 2024 |
| FY2022 | Oct 31, 2021 | $14.47M | Mar 29, 2023 |
| FY2021 | Oct 31, 2020 | $13.22M | Mar 17, 2023 |
| FY2020 | Oct 31, 2019 | $13.31M | Mar 17, 2023 |
| FY2019 | Oct 31, 2018 | $13.40M | Jan 29, 2020 |
| FY2018 | Oct 31, 2017 | $12.35M | Jan 29, 2019 |
| FY2017 | Oct 31, 2016 | $11.88M | Jan 29, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $701.9K | Jan 28, 2026 |
| FY2025 | Oct 31, 2024 | $1.38M | Jan 28, 2026 |
| FY2024 | Oct 31, 2023 | $2.73M | Jan 31, 2025 |
| FY2023 | Oct 31, 2022 | $2.52M | Feb 9, 2024 |
| FY2022 | Oct 31, 2021 | $3.70M | Mar 29, 2023 |
| FY2021 | Oct 31, 2020 | $2.88M | Mar 17, 2023 |
| FY2020 | Oct 31, 2019 | $2.40M | Mar 17, 2023 |
| FY2017 | Oct 31, 2017 | $2.33M | Jan 29, 2018 |
| FY2017 | Oct 31, 2016 | $3.23M | Jan 29, 2018 |
| FY2017 | Oct 31, 2015 | $3.85M | Jan 29, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 0 | Jan 28, 2026 |
| FY2025 | Oct 31, 2024 | 0 | Jan 28, 2026 |
| FY2024 | Oct 31, 2023 | 0 | Jan 31, 2025 |
| FY2023 | Oct 31, 2022 | 0 | Feb 9, 2024 |
| FY2022 | Oct 31, 2021 | 0 | Mar 29, 2023 |
| FY2021 | Oct 31, 2020 | 0 | Mar 17, 2023 |
| FY2020 | Oct 31, 2019 | 0 | Mar 17, 2023 |
| FY2013 | Oct 31, 2013 | 0 | Jan 24, 2014 |
| FY2013 | Oct 31, 2012 | 0 | Jan 24, 2014 |
| FY2012 | Oct 31, 2011 | 0 | Jan 28, 2013 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 0 | Jan 28, 2026 |
| FY2025 | Oct 31, 2024 | 0 | Jan 28, 2026 |
| FY2024 | Oct 31, 2023 | 0 | Jan 31, 2025 |
| FY2023 | Oct 31, 2022 | 0 | Feb 9, 2024 |
| FY2013 | Oct 31, 2013 | 0 | Jan 24, 2014 |
| FY2013 | Oct 31, 2012 | 0 | Jan 24, 2014 |
| FY2012 | Oct 31, 2011 | 0 | Jan 28, 2013 |
| FY2011 | Oct 31, 2010 | 0 | Jan 30, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 5.71M | Jan 28, 2026 |
| FY2025 | Oct 31, 2024 | 5.71M | Jan 28, 2026 |
| FY2024 | Oct 31, 2023 | 5.71M | Jan 31, 2025 |
| FY2023 | Oct 31, 2022 | 5.71M | Feb 9, 2024 |
| FY2022 | Oct 31, 2021 | 5.71M | Mar 29, 2023 |
| FY2021 | Oct 31, 2020 | 5.71M | Mar 17, 2023 |
| FY2020 | Oct 31, 2019 | 5.57M | Mar 17, 2023 |
| FY2019 | Oct 31, 2018 | 5.57M | Jan 29, 2020 |
| FY2018 | Oct 31, 2017 | 5.81M | Jan 29, 2019 |
| FY2017 | Oct 31, 2016 | 5.82M | Jan 29, 2018 |